Product Information

CICLOPIROX 8% SOLUTION is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $1.2137 per ML under NDC 45802014167. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Sep 18, 2007. Its Orange Book therapeutic-equivalence code is AT.

CICLOPIROX 8% SOLUTION

Ciclopirox
$1.2137per ML

Strength

80 mg/mL

NDC

45802014167

Classification

Generic

Dosage Form

SOLUTION

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

CICLOPIROX

Approval Type

Generic (ANDA)

FDA Application

ANDA077623

FDA Approved

9/18/2007

TE Code

AT

On Market Since

9/19/2007

Pharmacological Classes

Decreased DNA Replication
Decreased Protein Synthesis
Decreased RNA Replication
Protein Synthesis Inhibitors

Price Statistics

The NADAC for CICLOPIROX 8% SOLUTION has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 68.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2137 per ML
All-time high$4.6265 (Jan 15, 2014)
All-time low$1.1541 (Sep 23, 2026)
52-week high$1.3703
52-week low$1.1541
Median price$2.0239
Average price$2.4310
Largest weekly change-27.3% (Nov 20, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+3.9%

1M

+5.2%

3M

+3.6%

6M

-9.5%

1Y

-11.1%

3Y

-39.2%

5Y

-37.7%

All

-68.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CICLOPIROX 8% SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for CICLOPIROX 8% SOLUTION, manufactured by Padagis Israel Pharmaceuticals Ltd, is $1.2137 per ML (NDC 45802014167), effective Nov 18, 2026.

How has the price of CICLOPIROX 8% SOLUTION changed over time?

Over the history we have for it, the NADAC for CICLOPIROX 8% SOLUTION has declined 68.5%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CICLOPIROX 8% SOLUTION?

Since Nov 28, 2013, the NADAC for CICLOPIROX 8% SOLUTION has ranged from a low of $1.1541 (Sep 23, 2026) to a high of $4.6265 (Jan 15, 2014), with a median of $2.0239 per ML.

Are there cheaper alternatives to CICLOPIROX 8% SOLUTION?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CICLOPIROX 8% SOLUTION in a comparable dosage form, but none are currently priced below it.

Who manufactures CICLOPIROX 8% SOLUTION?

CICLOPIROX 8% SOLUTION (NDC 45802014167) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.